Aker Christopher Ray is an officer of Regulus Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Regulus Therapeutics Inc.
18 Jan 24
4
Regulus Therapeutics Inc.
17 Jan 24
4
Regulus Therapeutics Inc.
14 Aug 23
4/A
Regulus Therapeutics Inc.
17 Jan 23
4
Regulus Therapeutics Inc.
17 Jan 23
4
Regulus Therapeutics Inc.
11 May 22
4
Regulus Therapeutics Inc.
26 Jan 22
4
Regulus Therapeutics Inc.
17 May 21
4
Regulus Therapeutics Inc.
17 Feb 21
4
Regulus Therapeutics Inc.
5 Feb 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Jan 24 | RGLS Regulus Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 1.1906 | 5,468 | 6.51 k | 10,056 |
12 Jan 24 | RGLS Regulus Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 11,250 | 0.00 | 15,524 |
12 Jan 24 | RGLS Regulus Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.3 | 70,000 | 91.00 k | 70,000 |
10 Aug 23 | RGLS Regulus Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.36 | 393,750 | 535.50 k | 393,750 |
11 Jan 23 | RGLS Regulus Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.48 | 30,000 | 44.40 k | 30,000 |
11 Jan 23 | RGLS Regulus Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.48 | 45,000 | 66.60 k | 45,000 |